Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/28/1998 | EP0874057A2 Vector and mammalian cell line having improved productivity |
10/28/1998 | EP0874054A2 Vector for the expression of immunoglobulin-cytokine fusionproteins in malignant B Cells |
10/28/1998 | EP0874051A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines. |
10/28/1998 | EP0874050A2 Integrin ligand ITGL-TSP |
10/28/1998 | EP0874048A2 Human hedgehog protein |
10/28/1998 | EP0874046A1 A novel signal transduction factor and a gene encoding the same |
10/28/1998 | EP0874045A1 Novel dnas and process for producing proteins by using the same |
10/28/1998 | EP0873407A1 Apo-2 ligand |
10/28/1998 | EP0873405A1 Expression augmenting sequence elements (ease) for eukaryotic expression systems |
10/28/1998 | EP0873363A1 Novel high affinity human antibodies to tumor antigens |
10/28/1998 | EP0873354A1 Novel amp activated protein kinase |
10/28/1998 | EP0873349A1 Endothelial-monocyte activating polypeptide iii |
10/28/1998 | EP0873140A2 Immunoconjugate for the treatment of aids |
10/28/1998 | EP0759931B1 An enzymatic process for producing a desired protein from an amino terminal extended protein |
10/28/1998 | EP0407392B2 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
10/28/1998 | CN1197461A Truncated glial cell line-derived neurotrophic factor |
10/28/1998 | CN1197394A Compsns. and methods for catalyzing hydrolysis of HIV gp120 |
10/28/1998 | CN1197393A Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
10/28/1998 | CN1196956A Influenza vaccine |
10/28/1998 | CN1040459C Method for culture in acetic acid as indication |
10/28/1998 | CA2231746A1 A human sodium dependent phosphate transporter (ipt-1) |
10/27/1998 | US5827826 Compositions of human endothelial cell growth factor |
10/27/1998 | US5827824 Protease-resistant thrombomodulin analogs |
10/27/1998 | US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid |
10/27/1998 | US5827739 Recombinant DNA sequences, vectors containing them and method for the use thereof |
10/27/1998 | US5827733 Growth differentiation factor-8 (GDF-8) and polynucleotides encoding same |
10/27/1998 | US5827723 Neutralizing monoclonal antibody 0.5β which binds an epitope located within the region of amino acids 308-331 of HTLVIIB gp120 |
10/27/1998 | US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells |
10/27/1998 | US5827706 Nucleotide sequence which codes for cyclosporin synthetase and vectors containing the sequence |
10/27/1998 | US5827696 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
10/27/1998 | US5827691 Process for preparing a protein which inhibits metastasis of cancer |
10/27/1998 | US5827690 Transgenic production of antibodies in milk |
10/27/1998 | US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology |
10/27/1998 | US5827688 Secreted proteins and polynucleotides encoding them |
10/27/1998 | US5827684 Production of Bacillus entomotoxins in methylotrophic yeast |
10/27/1998 | US5827674 For diagnosis of cardiovascular or kidney disorders by immunoassay of atrial natriuretic polypeptide which binds to this antibody |
10/27/1998 | US5827671 Antibodies raised against proteins of Leishmania which are expressed at an increased level in the amastigote form |
10/27/1998 | US5827668 Immunodiagnostic assay for rheumatoid arthritis |
10/27/1998 | US5827666 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
10/27/1998 | US5827659 Methods and apparatus for sequencing polymers using mass spectrometry |
10/27/1998 | US5827647 Treating samples with isolated empty parvovirus capsids, then detecting antigen-antibody complexes for diagnosis, also kits |
10/27/1998 | US5827646 Comprising isolated epstein barr virus structural antigen and epstein barr nuclear antigen 1 |
10/27/1998 | US5827519 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
10/27/1998 | US5827515 Obtaining a dna segemnt containing spov dna sequence, introducing the segment into a bacillus thuringiensis host, isolating genetically engineered mutant capable of expressing exogenous crystal protein |
10/27/1998 | US5827514 Pesticidal compositions |
10/27/1998 | CA2078694C Hepatitis b vaccine |
10/27/1998 | CA2063721C Mycobacterium chelonae polar glycopeptidolipids-based immune booster medication |
10/27/1998 | CA2049017C Human-derived glycoprotein, biologically active factor which includes glyoprotein, and pharmaceutical product which comprises biologically active factor as active component |
10/27/1998 | CA1340103C Cloning of dna for protozoal antigens |
10/27/1998 | CA1340101C Amylolytic enzymes producing microorganisms, constructed by recombinant dna technology and their use for fermentation processes |
10/27/1998 | CA1340099C Method for in vitro immunisation of lymphocytes for use in production ofhuman monoclonal antibodies and kit therefor |
10/24/1998 | CA2228743A1 Novel integrin ligand itgl-tsp |
10/22/1998 | WO1998046795A1 Method for detection of recurrent prostate cancer |
10/22/1998 | WO1998046778A1 Transgenomic viruses and the use thereof |
10/22/1998 | WO1998046772A2 Gene conversion as a tool for the construction of recombinant industrial filamentous fungi |
10/22/1998 | WO1998046771A2 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same, related proteases, and therapeutic uses thereof |
10/22/1998 | WO1998046762A1 Plant fatty acid epoxygenase genes and uses therefor |
10/22/1998 | WO1998046761A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
10/22/1998 | WO1998046758A1 Human tumor-associated kazal inhibitor |
10/22/1998 | WO1998046751A1 Osteoprotegerin binding proteins and receptors |
10/22/1998 | WO1998046750A1 flt3 LIGAND CHIMERIC PROTEINS |
10/22/1998 | WO1998046745A1 NOVEL dlg FAMILY MOLECULE, POLYNUCLEOTIDE ENCODING THE SAME, ANTIBODY AGAINST THE SAME, AND METHOD FOR DETECTING dlg GENE |
10/22/1998 | WO1998046724A1 RECOMBINANT bHLH-PAS/JHR POLYPEPTIDE AND ITS USE TO SCREEN POTENTIAL INSECTICIDES |
10/22/1998 | WO1998046722A1 Direct expression of peptides into culture media |
10/22/1998 | WO1998046644A1 Novel protein and process for producing the same |
10/22/1998 | WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA |
10/22/1998 | WO1998046619A1 Glycine transporter |
10/22/1998 | WO1998046273A2 Delivery system for gene therapy to the brain |
10/22/1998 | WO1998046259A1 Non-antibiotic system for selection of recombinant mycobacteria |
10/22/1998 | WO1998031815A3 Subunits of nadh dehydrogenase |
10/22/1998 | WO1998022510A3 Methods for the production of chicken monoclonal antibodies |
10/22/1998 | DE19726012C1 Cyclic peptide or cyclic depsipeptide production |
10/22/1998 | CA2781623A1 Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same |
10/22/1998 | CA2706609A1 Osteoprotegerin binding proteins and receptors |
10/22/1998 | CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna |
10/22/1998 | CA2287779A1 Human tumor-associated kazal inhibitor |
10/22/1998 | CA2287526A1 Novel dlg family molecule, polynucleotide encoding the same, antibody against the same, and method for detecting dlg gene |
10/22/1998 | CA2286932A1 Recombinant bhlh-pas/jhr polypeptide and its use to screen potential insecticides |
10/22/1998 | CA2284127A1 Flt3 ligand chimeric proteins |
10/22/1998 | CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor |
10/22/1998 | CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor |
10/21/1998 | EP0872558A1 Monoclonal antibody recognizing serum amyloid a |
10/21/1998 | EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor |
10/21/1998 | EP0872488A1 MONOCLONAL ANTIBODY REACTING SPECIFICALLY WITH Fas LIGAND AND PROCESS FOR PRODUCING THE SAME |
10/21/1998 | EP0872487A2 Preparation of recombinant factor VIII in a protein free medium |
10/21/1998 | EP0871885A1 Attachment enhanced 293 cells |
10/21/1998 | EP0871884A1 Monospecific antibodies against a subunit of fibrinogen |
10/21/1998 | EP0871883A1 Compounds and methods related to parathyroid hormone-like protein |
10/21/1998 | EP0871776A1 A novel human b cell surface molecule |
10/21/1998 | EP0871763A1 Method for preparation of type ii collagen |
10/21/1998 | EP0871738A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
10/21/1998 | EP0871736A2 PESTICIDAL COMPOSITION COMPRISING CryIF CHIMERIC AND CryIA(c) CHIMERIC BACILLUS THURINGIENSIS DELTA-ENDOTOXIN |
10/21/1998 | EP0871733A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
10/21/1998 | EP0871727A2 Neuron-restrictive silencer factor proteins |
10/21/1998 | EP0871724A1 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus |
10/21/1998 | EP0871722A1 Post-transcriptional gene regulation by trace minerals |
10/21/1998 | EP0871721A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
10/21/1998 | EP0871720A2 Beta-secretase, antibodies to beta-secretase, and assays for detecting beta-secretase inhibition |
10/21/1998 | EP0871719A1 Psychrophilic protease and psychrophilic bacteria |
10/21/1998 | EP0871703A1 Dna encoding glutamate gated chloride channels |